yep. and this is a commodity wound care seller. i imagine EBIT margins wouldnt be too high- lots of sales and marketing in the Opex line..unlike CSL which doesnt need much sales and marketing.
Ann: Next Science Investor Presentation May 2019, page-9
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.030(8.00%) |
Mkt cap ! $105.0M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.0¢ | 34.5¢ | $8.4K | 24.05K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1570 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 3257 | 2 |
View Market Depth
| Last trade - 15.34pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
33.5¢ |
Change
-0.030 ( 10.7 %) |
||||
| Open | High | Low | Volume | ||
| 36.3¢ | 37.0¢ | 33.5¢ | 25927 | ||
| Last updated 15.58pm 16/05/2024 ? | |||||
| NXS (ASX) Chart |